BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 32512273)

  • 1. Prognostic impact of mucin spread, tumor cell spread, and invasive size in invasive mucinous adenocarcinoma of the lung.
    Saito T; Tsuta K; Honda O; Ishida M; Yamaka R; Tanaka N; Ishida K; Utsumi T; Maru N; Matsui H; Taniguchi Y; Hino H; Kurata T; Murakawa T
    Lung Cancer; 2020 Aug; 146():50-57. PubMed ID: 32512273
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Primary Invasive Mucinous Adenocarcinoma of the Lung: Prognostic Value of CT Imaging Features Combined with Clinical Factors.
    Wang T; Yang Y; Liu X; Deng J; Wu J; Hou L; Wu C; She Y; Sun X; Xie D; Chen C
    Korean J Radiol; 2021 Apr; 22(4):652-662. PubMed ID: 33236544
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimal method for measuring invasive size that predicts survival in invasive mucinous adenocarcinoma of the lung.
    Oki T; Aokage K; Nomura S; Tane K; Miyoshi T; Shiiya N; Funai K; Tsuboi M; Ishii G
    J Cancer Res Clin Oncol; 2020 May; 146(5):1291-1298. PubMed ID: 32088782
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic analysis of primary mucin-producing adenocarcinoma of the lung: a comprehensive retrospective study.
    Qu Y; Zhao D; Mu J; Che N; Zhang C; Liu Z; Su D; Zhou L; Zhang H; Wei L
    Tumour Biol; 2016 Jan; 37(1):887-96. PubMed ID: 26254613
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognosis in Resected Invasive Mucinous Adenocarcinomas of the Lung: Related Factors and Comparison with Resected Nonmucinous Adenocarcinomas.
    Lee HY; Cha MJ; Lee KS; Lee HY; Kwon OJ; Choi JY; Kim HK; Choi YS; Kim J; Shim YM
    J Thorac Oncol; 2016 Jul; 11(7):1064-73. PubMed ID: 27016260
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lepidic predominant adenocarcinoma and invasive mucinous adenocarcinoma of the lung exhibit specific mucin expression in relation with oncogenic drivers.
    Duruisseaux M; Antoine M; Rabbe N; Rodenas A; Mc Leer-Florin A; Lacave R; Poulot V; Duchêne B; Van Seuningen I; Cadranel J; Wislez M
    Lung Cancer; 2017 Jul; 109():92-100. PubMed ID: 28577958
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of intracytoplasmic mucin in lung adenocarcinoma with pneumonic radiological presentation.
    Duruisseaux M; Antoine M; Rabbe N; Poulot V; Fleury-Feith J; Vieira T; Lavolé A; Cadranel J; Wislez M
    Lung Cancer; 2014 Mar; 83(3):334-40. PubMed ID: 24461303
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the immunotherapy efficacy between invasive mucinous and non-mucinous adenocarcinoma in advanced lung cancer patients with KRAS mutation: a retrospective study.
    Xu M; Hao Y; Zhou H; Shi Z; Si J; Song Z
    Med Oncol; 2023 Jun; 40(7):198. PubMed ID: 37294384
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic factors for invasive mucinous adenocarcinoma of the lung: systematic review and meta-analysis.
    Zhao T; Yi J; Luo D; Liu J; Fan X; Wu Q; Wang W
    World J Surg Oncol; 2024 Feb; 22(1):41. PubMed ID: 38303008
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spread through air spaces (STAS) in invasive mucinous adenocarcinoma of the lung: Incidence, prognostic impact, and prediction based on clinicoradiologic factors.
    Lee MA; Kang J; Lee HY; Kim W; Shon I; Hwang NY; Kim HK; Choi YS; Kim J; Zo JI; Shim YM
    Thorac Cancer; 2020 Nov; 11(11):3145-3154. PubMed ID: 32975379
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anaplastic lymphoma kinase fusion protein expression is associated with a favorable prognosis in resected invasive mucinous lung adenocarcinoma: A retrospective study from two Chinese tertiary hospitals.
    Wang J; Wei P; Liu J; Su P; Xing A; Jing H; Hao J
    J Cancer Res Ther; 2022 Apr; 18(2):445-451. PubMed ID: 35645113
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognosis of resected invasive mucinous adenocarcinoma compared with the IASLC histologic grading system for invasive nonmucinous adenocarcinoma: Surgical database study in the TKIs era in Korea.
    Woo W; Yang YH; Cha YJ; Moon DH; Shim HS; Cho A; Kim BJ; Kim HE; Park BJ; Lee JG; Kim DJ; Paik HC; Lee S; Lee CY
    Thorac Cancer; 2022 Dec; 13(23):3310-3321. PubMed ID: 36345148
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of Surgical Outcomes Between Invasive Mucinous and Non-Mucinous Lung Adenocarcinoma.
    Matsui T; Sakakura N; Koyama S; Nakanishi K; Sasaki E; Kato S; Hosoda W; Murakami Y; Kuroda H; Yatabe Y
    Ann Thorac Surg; 2021 Oct; 112(4):1118-1126. PubMed ID: 33242433
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ¹⁸F-fluorodeoxyglucose uptake on positron emission tomography in mucinous adenocarcinoma.
    Murakami S; Saito H; Karino F; Kondo T; Oshita F; Ito H; Nakayama H; Yokose T; Yamada K
    Eur J Radiol; 2013 Nov; 82(11):e721-5. PubMed ID: 23988690
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The prognostic role of pathologic invasive component size, excluding lepidic growth, in stage I lung adenocarcinoma.
    Tsutani Y; Miyata Y; Mimae T; Kushitani K; Takeshima Y; Yoshimura M; Okada M
    J Thorac Cardiovasc Surg; 2013 Sep; 146(3):580-5. PubMed ID: 23778085
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Construction of a Prognostic Prediction Model of Patients with Pathologic N0 
in Resected Invasive Mucinous Adenocarcinoma of the Lung].
    Wang Z; He J; Shen H; Chen X; Lin C; Yu H; Gao J; He X; Shen W
    Zhongguo Fei Ai Za Zhi; 2024 Jan; 27(1):47-55. PubMed ID: 38296625
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of the clinicopathologic characteristics and prognostic of stage I invasive mucinous adenocarcinoma.
    Luo J; Wang R; Han B; Zhang J; Zhao H; Fang W; Luo Q; Yang J; Yang Y; Zhu L; Chen T; Cheng X; Huang Q; Wang Y; Zheng J; Chen H
    J Cancer Res Clin Oncol; 2016 Aug; 142(8):1837-45. PubMed ID: 27342421
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prediction for prognosis of resected pT1a-1bN0M0 adenocarcinoma based on tumor size and histological status: relationship of TNM and IASLC/ATS/ERS classifications.
    Ito M; Miyata Y; Kushitani K; Yoshiya T; Mimae T; Ibuki Y; Misumi K; Takeshima Y; Okada M
    Lung Cancer; 2014 Aug; 85(2):270-5. PubMed ID: 24976332
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Postoperative survival of pulmonary invasive mucinous adenocarcinoma versus non-mucinous invasive adenocarcinoma.
    Cui D; Xie S; Liu Q
    BMC Pulm Med; 2023 Jan; 23(1):9. PubMed ID: 36624430
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparing clinicopathological features and prognosis of primary pulmonary invasive mucinous adenocarcinoma based on computed tomography findings.
    Nie K; Nie W; Zhang YX; Yu H
    Cancer Imaging; 2019 Jul; 19(1):47. PubMed ID: 31292000
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.